How to win: Botulinum Antitoxin Heptavalent (2026)

About this contract

UKHSA is inviting suppliers to participate in a preliminary market engagement exercise for Botulinum Antitoxin Heptavalent (HBAT) through this Request for Information (RFI), in accordance with the Procurement Act 2023. The purpose of this exercise is to gather information on available products, supplier capability, and market conditions to inform a potential future procurement.

How to win contracts like this

• ✓Answer against the marking scheme, not the question text — Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency scores each response, so map your evidence to the published criteria and weightings.
• ✓At £1, expect quality and social value to carry a large share of the score — price alone rarely wins goods work.
• ✓Show recent, comparable delivery: name similar goods contracts you've delivered for public bodies, with measurable outcomes.
• ✓Start early: deadlines are tight and a strong bid takes iteration.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources

Similar contracts